BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Autoimmunity, Quercetin, rs4950928, CXCL2, Metabolism of xenobiotics, Influenza, Embryo)
Bookmark Forward

QuickView for semaphorin 3a (gene)


Body Atlas

Most Correlated Tissues

  1. Skeletal muscle psoas
  2. Atrioventricular node
  3. Superior cervical ganglion
  4. Tongue
  5. Appendix
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Lissencephaly
  2. Rhinitis
  3. Disorder of pituitary gland
  4. Disorder of endocrine gonad
  5. Pyloric ulcer
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. N-methylolacrylamide
  2. Benzodiazepinones
  3. Sonic Hedgehog Protein
  4. Diterpenes
  5. Transforming Growth Factor beta2
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ANKRD52
  2. STAU2
  3. TRPC6
  4. GSN
  5. arm
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Assessment of semaphorin 3A and semaphorin 7A levels in primary Sjogren's syndrome.
  2. Pinpointing the interaction site between semaphorin-3A and its inhibitory peptide.
  3. Emerging roles and mechanisms of semaphorins activity in cancer.
  4. Evaluation of serum semaphorin 3A and interleukin 6 levels in patients with pseudoexfoliation syndro…
  5. Semaphorin 3A: A potential target for prevention and treatment of nickel allergy.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Semaphorins 3A and 4D Levels in Heart Failure Patients
  2. Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis
  3. Determination of the Levels of Lipocalin-2 and Semaphorin3A
  4. Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors
  5. Evaluation of Novel Biomarkers in Early Recognition of Acute Kidney Injury After Orthopedic Operatio…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.